Opioid Use in the Nondialysis Chronic Kidney Disease Population
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 41 (1) , 33-41
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- Adverse Effects in Hospice Patients with Chronic Kidney Disease Receiving HydromorphoneJournal of Palliative Medicine, 2011
- Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1βNeuroscience, 2010
- Understanding Symptoms in Patients with Advanced Chronic Kidney Disease Managed without Dialysis: Use of a Short Patient-Completed Assessment ToolNephron Clinical Practice, 2008
- Opioid Rotation from Oral Morphine to Oral Oxycodone in Cancer Patients with Intolerable Adverse Effects: An Open-Label TrialJapanese Journal of Clinical Oncology, 2008
- Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2007
- Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug managementCancer, 2007
- Efficacy of the World Health Organization Analgesic Ladder to Treat Pain in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2006
- Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatientsJournal of Pain and Symptom Management, 1997
- Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPain, 1995